Evidence map›Paper›PMID 31456500›Full record

ArticleJournal of managed care & specialty pharmacy2019

Letter--The Authors Respond.

Sarah Hollmann, Daniel Moldaver, Nik Goyert, Daniel Grima, Eric M Maiese

Abstract readLetter
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sarah HollmannCornerstone Research Group Burlington, Ontario, Canada.
Daniel MoldaverCornerstone Research Group Burlington, Ontario, Canada.
Nik GoyertCornerstone Research Group Burlington, Ontario, Canada.
Daniel GrimaCornerstone Research Group Burlington, Ontario, Canada.
Eric M MaieseJanssen Scientific Affairs Horsham, PA emaiese@ITS.JNJ.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

disclosuresNo additional funding was received for the writing of this letter. The published study referred to in this letter was funded by Janssen Scientific Affairs, which employs Maiese and funded Cornerstone Research Group, a health economic consulting group, to conduct the study. Grima is a founding partner of Cornerstone Research Group, which employs Hollmann, Goyert, and Moldaver.

Indexed as

HumansMultiple MyelomaProgression-Free SurvivalQuality of LifeUnited StatesUnited States Food and Drug Administration

Identifiers

PMID31456500
PMCPMC10398007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.